Bare Financial Services »

Rapport Therapeutics shares owned by Bare Financial Services

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Bare Financial Services from 13F filings

Historical chart of Bare Financial Services investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by Bare Financial Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by Bare Financial Services

Quarter filed Position value Share count Share price at filing
2025-12-31 $485 16 30.31

More positions owned by Bare Financial Services

Ishares Core S&p 500 Etf Etf (IVV)
Ishares Core Msci Eafe Etf Etf (IEFA)
Vanguard Value Etf Etf (VTV)
Vanguard Total Bond Market Etf Etf (BND)
Avantis U.s. Small Cap Value Etf Etf (AVUV)
Inspire International Etf Etf (WWJD)
Inspire Corporate Bond Etf Etf (IBD)
Pimco Multisector Bond Active Exchange-traded Fund Etf (PYLD)
Crossmark Large Cap Growth Etf Etf (CLCG)
Vanguard Russell 1000 Growth Etf Etf (VONG)
Eventide High Dividend Etf Etf (ELCV)
Ishares Msci Emerging Markets Ex China Etf Etf (EMXC)
Timothy Plan Us Small Cap Core Etf Etf (TPSC)
Timothy Plan Us Large/mid Cap Core Etf Etf (TPLC)
Vanguard Mid-cap Growth Etf Etf (VOT)

View all positions for Bare Financial Services

Top funds holding Rapport Therapeutics

TRV GP V
FMR
Arch Venture Corp
Capital Research and Management Company - Division 3
Cormorant Asset Management
Goldman Sachs Group
BlackRock
Sofinnova Ventures
Vanguard Group
Johnson & Johnson
Baker Bros. Advisors
Vestal Point Capital
Polar Capital Holdings
Trv Gp Vi
Ubs Global Asset Management Americas

View all funds holding Rapport Therapeutics